Typicality: | 0.441 |
Saliency: | 0.364 |
despite a history of failures | 5 | other |
effectively | 2 | manner |
drug → target → beta-amyloid | 23 |
drug → target → amyloid | 13 |
drug → target → beta amyloid | 7 |
drug → target → amyloid plaques | 3 |
negative | neutral | positive |
0.469 | 0.429 | 0.102 |
Raw frequency | 46 |
Normalized frequency | 0.364 |
Modifier score | 0.880 |
Perplexity | 19.276 |